McCarthy is seeking consistency under the prime-time lights at “Jerry World,” or AT&T Stadium, where the Vikings will travel ...

McCarthy was 16-for-23 for 163 yards and three touchdowns in Sunday's 31-0 win. But his performance set the stage for ...

A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an approximately $8 billion proposed settlement that would end tens of thousands ...

EAGAN, Minn. -- The breeze is starting to cool off around the Twin Cities, just as the murmurs of expectation around another Minnesota Vikings season begin to heat up. Except no one ever quite knows ...

The Green Bay Packers will face Minnesota Vikings quarterback J.J. McCarthy for the first time on Sunday, and the first-year starter is really struggling through his first five NFL starts. Can the ...

This almost felt inevitable but J.J. McCarthy is expected to return for Week 9's battle against the Detroit Lions. Minnesota is under .500 and now Carson Wentz will need shoulder surgery on his ...

Perhaps more importantly for the Pittsburgh Steelers pass rusher is that he became No. 1 in the Watt family. Watt strip-sacked Chicago Bears quarterback Caleb Williams in the second quarter of ...

Johnson & Johnson must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle ...

NEW YORK, Aug 14 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab is preparing to unveil widespread support in coming days for a $6.48 billion offer to settle tens of thousands of legal actions ...

Company denies claims its talc products caused cancer J&J calls "fair and equitable to all parties" Sept 20 (Reuters) - A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday ...

Johnson & Johnson has informed the Health Resources and Services Administration (HRSA) that it has "no choice but to forgo implementation" of its controversial plan to swap out upfront 340B drug ...